Heterologous Vector versus Homologous mRNA COVID-19 Booster Vaccination in Non-Seroconverted Immunosuppressed Patients: A Randomized Controlled Trial

Impaired response to COVID-19 vaccination is of particular concern in immunosuppressed patients. To determine the best vaccination strategy for this vulnerable group, researchers performed a single center, 1:1 randomized blinded clinical trial.